United States Pharmaceuticals

Amneal Pharmaceuticals Inc (AMRX)

Track

Over the past 90 days, Amneal Pharmaceuticals Inc. recorded two insider transactions, both involving sales totaling approximately $450,558. These transactions occurred following the company's May 2026 earnings report, which showed a significant EPS beat. The stock has experienced a 42.6% price increase over the last quarter, currently trading near its 52-week high.
Ticker: AMRX Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Amneal Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 11 May 2026
Value US$192,550.80 | Price 429.32 | Shares 59,030 (-15.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-11 S Sale
2.0
Autor Deborah M.
Non-Executive Director
59,030 -15.9%
429.32
US$192,551 		59,030 -15.9% 429.32 US$192,551
2026-05-11 2026-05-11 PrS Proposed sale
2.0
DEBORAH AUTOR

DIRECTOR

Non-Executive Director
49,866
372.11
US$917,363 		49,866 372.11 US$917,363
2025-11-19 2025-11-17 S Sale
0.8
Nark Ted C
Non-Executive Director
54,121 -21.0%
123.32
US$1,379,435 		54,121 -21.0% 123.32 US$1,379,435
2025-11-17 2025-11-17 PrS Proposed sale
0.8
Nark Ted C

Director

Non-Executive Director
50,000
11.83
US$591,250 		50,000 11.83 US$591,250
2025-11-14 2025-11-12 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
131,856 -47.4%
11.92
US$1,571,724 		131,856 -47.4% 11.92 US$1,571,724
2025-11-12 2025-11-12 PrS Proposed sale
2.1
NIKITA SHAH

OFFICER

Officer
131,856
11.92
US$1,571,723 		131,856 11.92 US$1,571,723
2025-08-28 2025-08-27 S Sale
2.3
Kiely John
Non-Executive Director
32,000 -12.4%
9.23
US$295,360 		32,000 -12.4% 9.23 US$295,360
2025-08-27 2025-08-27 PrS Proposed sale
2.3
Kiely John

Director

Non-Executive Director
32,000
9.18
US$293,810 		32,000 9.18 US$293,810
2025-08-25 2025-08-25 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
6,340 -4.2%
9.50
US$60,230 		6,340 -4.2% 9.50 US$60,230
2025-08-25 2025-08-22 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
114,492 -42.8%
9.66
US$1,105,993 		114,492 -42.8% 9.66 US$1,105,993
2025-08-22 2025-08-22 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
36,796
9.70
US$356,921 		36,796 9.70 US$356,921
2025-08-22 2025-08-22 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
84,036
9.75
US$818,931 		84,036 9.75 US$818,931
2025-08-22 2025-08-20 S Sale
1.5
BOYER ANDREW S

Executive Vice President

Officer
279,244 -64.7%
9.38
US$2,619,309 		279,244 -64.7% 9.38 US$2,619,309
2025-08-20 2025-08-20 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
175,000
9.36
US$1,637,900 		175,000 9.36 US$1,637,900
2025-08-20 2025-08-20 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
104,244
9.30
US$969,469 		104,244 9.30 US$969,469
2025-08-15 2025-08-15 PrS Proposed sale
1.7
Konidaris Tasos

Officer

Officer
219,159
9.39
US$2,057,903 		219,159 9.39 US$2,057,903
2025-08-15 2025-08-15 S Sale
1.7
Konidaris Tasos

Executive Vice President & CFO

Officer
219,159 -64.2%
9.43
US$2,066,669 		219,159 -64.2% 9.43 US$2,066,669
2025-08-15 2025-08-14 S Sale
1.7
Konidaris Tasos

Executive Vice President & CFO

Officer
119,206 -25.9%
9.30
US$1,108,616 		119,206 -25.9% 9.30 US$1,108,616
2025-08-15 2025-08-14 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
71,694 -21.2%
9.29
US$666,037 		71,694 -21.2% 9.29 US$666,037
2025-08-14 2025-08-14 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
71,694
9.25
US$663,065 		71,694 9.25 US$663,065
2025-08-15 2025-08-13 S Sale
1.7
Konidaris Tasos

Executive Vice President & CFO

Officer
161,365 -25.9%
9.22
US$1,487,785 		161,365 -25.9% 9.22 US$1,487,785
2025-08-13 2025-08-13 PrS Proposed sale
1.7
Konidaris Tasos

Officer

Officer
169,206
9.27
US$1,568,539 		169,206 9.27 US$1,568,539
2025-08-13 2025-08-13 PrS Proposed sale
1.7
Konidaris Tasos

Officer

Officer
111,635
9.02
US$1,006,947 		111,635 9.02 US$1,006,947
2025-08-13 2025-08-12 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
50,000 -12.9%
9.04
US$452,000 		50,000 -12.9% 9.04 US$452,000
2025-08-13 2025-08-12 S Sale
1.5
BOYER ANDREW S

Executive Vice President

Officer
33,436 -11.5%
9.05
US$302,596 		33,436 -11.5% 9.05 US$302,596
2025-08-13 2025-08-12 S Sale
3.3
Daly Jason B.

EVP, Chief Legal Officer

Officer
22,000 -67.5%
9.05
US$199,100 		22,000 -67.5% 9.05 US$199,100
2025-08-12 2025-08-12 PrS Proposed sale
3.3
Daly Jason B.

Officer

Officer
22,000
9.00
US$198,000 		22,000 9.00 US$198,000
2025-08-12 2025-08-12 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
33,436
9.09
US$304,100 		33,436 9.09 US$304,100
2025-08-12 2025-08-12 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
50,000
9.06
US$453,000 		50,000 9.06 US$453,000
2025-06-18 2025-06-16 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
94,906 -5.6%
8.02
US$761,146 		94,906 -5.6% 8.02 US$761,146
2025-06-12 2025-06-10 S Sale
2.6
Patel Gautam
Non-Executive Director
56,426 -3.2%
8.02
US$452,537 		56,426 -3.2% 8.02 US$452,537
2025-05-19 2025-05-16 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
49,140 -11.2%
7.58
US$372,481 		49,140 -11.2% 7.58 US$372,481
2025-05-16 2025-05-16 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
49,140
7.50
US$368,550 		49,140 7.50 US$368,550
2025-05-13 2025-05-12 S Sale
2.3
Kiely John
Non-Executive Director
50,000 -16.3%
7.59
US$379,500 		50,000 -16.3% 7.59 US$379,500
2025-05-12 2025-05-12 PrS Proposed sale
2.3
Kiely John

Director

Non-Executive Director
50,000
7.57
US$378,500 		50,000 7.57 US$378,500
2025-05-06 2025-05-05 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
4,900 -0.3%
8.00
US$39,200 		4,900 -0.3% 8.00 US$39,200
2025-05-06 2025-05-02 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
3,768 -0.2%
8.00
US$30,144 		3,768 -0.2% 8.00 US$30,144
2025-05-02 2025-05-02 PrS Proposed sale
2.6
Gautam Patel

Director

Non-Executive Director
160,000
7.74
US$1,238,400 		160,000 7.74 US$1,238,400
2025-04-02 2025-04-01 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
80,000 -4.4%
8.30
US$664,000 		80,000 -4.4% 8.30 US$664,000
2025-03-17 2025-03-14 S Sale
2.4
Patel Tushar Bhikhubhai
Large shareholder
5,000,000 -9.3%
8.35
US$41,750,000 		5,000,000 -9.3% 8.35 US$41,750,000
2025-03-14 2025-03-14 PrS Proposed sale
2.4
Patel Tushar Bhikhubhai

10% Stockholder

Large shareholder
5,000,000
8.75
US$43,750,000 		5,000,000 8.75 US$43,750,000
2025-03-07 2025-03-06 S Sale
3.3
Daly Jason B.

EVP, Chief Legal Officer

Officer
46,936 -59.0%
8.73
US$409,751 		46,936 -59.0% 8.73 US$409,751
2025-03-07 2025-03-05 S Sale
3.3
Daly Jason B.

EVP, Chief Legal Officer

Officer
43,064 -35.1%
8.88
US$382,408 		43,064 -35.1% 8.88 US$382,408
2025-03-07 2025-03-05 S Sale
3.0
Alva Emily Peterson
Non-Executive Director
80,000 -31.9%
8.90
US$712,000 		80,000 -31.9% 8.90 US$712,000
2025-03-07 2025-03-05 S Sale
1.5
BOYER ANDREW S

Executive Vice President

Officer
125,000 -30.1%
8.89
US$1,111,250 		125,000 -30.1% 8.89 US$1,111,250
2025-03-07 2025-03-05 S Sale
1.7
Konidaris Tasos

Executive Vice President & CFO

Officer
100,000 -13.9%
8.91
US$891,000 		100,000 -13.9% 8.91 US$891,000
2025-03-05 2025-03-05 PrS Proposed sale
3.0
Alva Emily Peterson

Director

Non-Executive Director
85,000
8.87
US$753,950 		85,000 8.87 US$753,950
2025-03-05 2025-03-05 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
125,000
8.87
US$1,108,750 		125,000 8.87 US$1,108,750
2025-03-05 2025-03-05 PrS Proposed sale
3.3
Daly Jason B.

Officer

Officer
90,000
8.80
US$792,000 		90,000 8.80 US$792,000
2025-03-05 2025-03-05 PrS Proposed sale
1.7
Konidaris Tasos

Officer

Officer
100,000
8.84
US$884,000 		100,000 8.84 US$884,000
2025-03-05 2025-03-03 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
80,000 -4.2%
8.90
US$712,000 		80,000 -4.2% 8.90 US$712,000
2025-02-05 2025-02-03 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
80,000 -4.1%
8.14
US$651,200 		80,000 -4.1% 8.14 US$651,200
2025-01-10 2025-01-08 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
62,590 -3.1%
8.01
US$501,346 		62,590 -3.1% 8.01 US$501,346
2025-01-06 2025-01-02 PlS Planned sale
2.6
Patel Gautam
Non-Executive Director
17,410 -0.8%
8.01
US$139,454 		17,410 -0.8% 8.01 US$139,454
2025-01-02 2025-01-02 PrS Proposed sale
2.6
Gautam J Patel

Director

Non-Executive Director
320,000
8.00
US$2,560,000 		320,000 8.00 US$2,560,000
2024-11-26 2024-11-22 S Sale
2.3
Kiely John
Non-Executive Director
17,058 -6.0%
8.38
US$142,946 		17,058 -6.0% 8.38 US$142,946
2024-11-25 2024-11-22 S Sale
2.0
Autor Deborah M.
Non-Executive Director
33,229 -38.4%
8.34
US$277,130 		33,229 -38.4% 8.34 US$277,130
2024-11-22 2024-11-22 PrS Proposed sale
2.3
Kiely John

Director

Non-Executive Director
17,058
8.33
US$142,175 		17,058 8.33 US$142,175
2024-11-25 2024-11-21 S Sale
2.0
Autor Deborah M.
Non-Executive Director
6,771 -7.2%
8.41
US$56,944 		6,771 -7.2% 8.41 US$56,944
2024-11-22 2024-11-21 S Sale
3.3
Daly Jason B.

SVP, Chief Legal Officer

Officer
13,665 -100.0%
8.40
US$114,786 		13,665 -100.0% 8.40 US$114,786
2024-11-21 2024-11-21 PrS Proposed sale
2.0
Autor Deborah M.

Director

Non-Executive Director
50,000
8.38
US$419,000 		50,000 8.38 US$419,000
2024-11-19 2024-11-15 S Sale
3.3
Daly Jason B.

SVP, Chief Legal Officer

Officer
43,657 -76.2%
8.61
US$375,887 		43,657 -76.2% 8.61 US$375,887
2024-11-15 2024-11-15 PrS Proposed sale
3.3
Daly Jason B.

Officer

Officer
57,322
8.50
US$487,237 		57,322 8.50 US$487,237
2024-08-16 2024-08-15 S Sale
1.5
BOYER ANDREW S

Executive Vice President

Officer
40,225 -13.5%
7.85
US$315,766 		40,225 -13.5% 7.85 US$315,766
2024-08-16 2024-08-14 S Sale
2.1
Shah Nikita

Executive Vice President

Officer
100,000 -25.5%
7.75
US$775,000 		100,000 -25.5% 7.75 US$775,000
2024-08-16 2024-08-14 S Sale
1.5
BOYER ANDREW S

Executive Vice President

Officer
22,486 -7.0%
7.81
US$175,616 		22,486 -7.0% 7.81 US$175,616
2024-08-14 2024-08-14 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
70,000
7.80
US$546,000 		70,000 7.80 US$546,000
2024-08-14 2024-08-14 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
70,000
7.86
US$550,200 		70,000 7.86 US$550,200
2024-08-14 2024-08-14 PrS Proposed sale
2.1
Shah Nikita

Officer

Officer
30,000
7.86
US$235,800 		30,000 7.86 US$235,800
2024-05-20 2024-05-17 S Sale
2.0
Autor Deborah M.
Non-Executive Director
23,447 -20.1%
6.73
US$157,728 		23,447 -20.1% 6.73 US$157,728
2024-05-20 2024-05-16 S Sale
2.0
Autor Deborah M.
Non-Executive Director
14,553 -11.1%
6.76
US$98,378 		14,553 -11.1% 6.76 US$98,378
2024-05-16 2024-05-16 PrS Proposed sale
2.0
Autor Deborah M.

Director

Non-Executive Director
38,000
6.87
US$261,000 		38,000 6.87 US$261,000
2023-08-15 2023-08-11 S Sale
1.5
BOYER ANDREW S

Executive Vice President

Officer
29,302 -10.7%
4.13
US$120,921 		29,302 -10.7% 4.13 US$120,921
2023-08-11 2023-08-11 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
8,302
3.96
US$32,837 		8,302 3.96 US$32,837
2023-08-11 2023-08-11 PrS Proposed sale
1.5
BOYER ANDREW S

Officer

Officer
21,000
4.22
US$88,620 		21,000 4.22 US$88,620
Explore more

More insider trading research around Amneal Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America